Assessment of DNA strand breakage by the alkaline Comet assay in dialysis patients and the role of Vitamin E supplementation

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 520, Issue 1-2, 2002, Pages 151-159

  Kan, Erdal ^a   Ündeǧer, Ülkü ^b   Bali, Musa ^a   Başaran, Nurşen ^b  

^a GAZI UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chronic renal failure; Comet assay; Dialysis; Oxidative DNA damage; Vitamin E supplementation

Indexed keywords

ALPHA TOCOPHEROL;

ADULT; AGE; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG EFFECT; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SEX; SMOKING HABIT; UREMIA; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTIOXIDANTS; COMET ASSAY; DIETARY SUPPLEMENTS; DNA DAMAGE; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; SMOKING; UREMIA; VITAMIN E;

EID: 0037179502     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00205-X     Document Type: Article

References (46)

1. Descamps-Latscha B., Herbelin A., Nyugen A.T., Zingraff J., Jungers P., Chatenoud L. Immune system dysregulation in uremia. Semin. Nephrol. 14:1994;253-260.
2. Nguyen A.T., Lethias C., Zingraff J., Herbelin A., Naret C., Descamps-Latscha B. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within micro amounts of whole blood. Kidney Int. 28:1985;158-167.
3. Dasgupta A., Hussain S., Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron. 60:1992;56-59.
4. Galli F., Rovidati S., Chiarantini L., Kulurianu H., Canestrari F., Buonaristani U. Bioreactivity and biocompatibility of a Vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 54:1998;580-589.
5. Gorillo C., Oliviero C., Rizzuti G., Nediani C., Pacini A., Nassi P. Oxidative stress and antioxidant defences in renal patients receiving regular hemodialysis. Clin. Chem. Lab. Med. 36:1998;149-153.
6. Bochev P., Tzvetkov N., Alexandrova M.et al. Development of oxidative stress in chronic kidney insufficiency following the progression of disease. Nephron. 77:1997;244-245.
7. Taylor J.E., Scott N., Bridges A., Henderson I.S., Steward W.K., Belch J.J. Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients. Perit. Dial. Int. 12:1992;252-256.
8. Sarsat V.W., Friedlander M., Capeillere-Blandin C., Nyugen-Khoa T., Nyugen A.T., Zingraff J., Jungers P., Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:1996;1304-1313.
9. Hashimoto H., Mio T., Sumino K. Lipid abnormalities of erythrocyte membranes in hemodialysis patients with chronic renal failure. Clin. Chim. Acta. 252:1996;137-145.
10. Clermont G., Lecour S., Lahet J., Siohan P., Vergely C., Chevet D., Rifle G., Rochette L. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc. Res. 47:2000;618-623.
11. Canestrari F., Galli F., Giorgini A., Albertini M.C., Galiotta P., Pascucci M., Bossu M. Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol. 91:1994;187-193.
12. Chen C.K., Liaw J.M., Juang J.G., Lin T.H. Antioxidant enzymes and trace elements in hemodialyzed patients. Biol. Trace Element Res. 58:1997;149-157.
13. Ross E.A., Koo L.C., Moberly J.B. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am. J. Kidney Dis. 30:1997;489-494.
14. Steiner M. Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and carebrovascular disease. Nutr. Rev. 57:1999;306-309.
15. Kikuchi Y., Koyama T., Koyama Y., Tozawa S., Arai T., Horimoto M., Kakiuchi Y. Red blood cell deformability in renal failure. Nephron. 30:1982;8-14.
16. Ritz E., Deppisch R., Sitier E., Hansch G. Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? Nephrol. Dial. Transplant. 9:1994;165-172.
17. Huysmans K., Lins R.I., Daelemans R., Zachee P., DeBroe M.E. Hypertension and accelerated atherosclerosis in endstage renal disease. J. Nephrol. 11:1998;185-195.
18. Giardini O., Taccone-Gallucci M., Lubrano R., Ricciardi-Tenore G., Bandino D., Silvi I., Paradisi C., Mannarino O., Citti G., Elli M., Casciani C.U. Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients. Clin. Nephrol. 21:1984;174-177.
19. Lubrano R., Taccone-Gallucci M., Mazzarella V., Bandino D., Citti G., Elli M., Giardini O., Casciani C.U. Relationship between red blood cell lipid peroxidation, plasma hemoglobin, and red blood cell osmotic resistance before and after Vitamin E supplementation in hemodialysis patients. Artif. Organs. 10:1986;245-250.
20. Taccone-Gallucci M., Lubrano R., Del Prinipe D., Menichelli A., Giordani M., Citti G., Morosetti M., Meloni C., Mazzarella V., Meschini L., Tozzo C., Elli M., Giardini O., Casciani C.U. Platelet lipid peroxidation in haemodialysis patients: effects of Vitamin E supplementation. Nephrol. Dial. Transplant. 4:1989;975-978.
21. Pastor M.C., Sierra C., Bonal J., Teixido J. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis. Am. J. Nephrol. 13:1993;238-243.
22. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Laina A., Knecht A., Weissgorten Y., Brunner D., Fainoru F., Green M.S. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 356:2000;1213-1218.
23. Anderson D., Yu T.-W., Philips B.J., Schmezer P. The effect of various antioxidant and other modifying agents on oxygen-radical generated DNA damage in human lymphocytes in the Comet assay. Mutat. Res. 307:1994;261-271.
24. Fairbairn D.W., Olive P.L., O'Neill K.L. The comet assay: a comprehensive review. Mutat. Res. 339:1995;37-59.
25. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. 5:1976;9-15.
26. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell. Res. 175:1988;184-191.
27. Anderson D., Yu T.-W., Phillips B.J., Schmezer P. The effect of various antioxidant and other modifying agents on oxygen-radical generated DNA damage in human lymphocytes in the comet assay. Mutat. Res. 307:1994;261-271.
28. Andreoli S.P. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr. Nephrol. 5:1991;733-742.
29. Galli F., Canestrari F., Buoncristani U. Biological effects of oxidant stress in haemodialysis: the possible roles of Vitamin E. Blood Purif. 17:1999;79-94.
30. Vamvakas S., Bahner U., Becker P., Steinle A., Götz R., Heidland A. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation. Transplant. Proc. 28:1996;3468-3473.
31. Stopper H., Meysen T., Biockenförde A., Bahner U., Heidland A., Vamvakas S. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am. J. Kidney Dis. 34:1999;433-437.
32. Stopper H., Boullay F., Heidland A., Vienken J., Bahner U. Comet assay analysis identifies genomic damage in lymphocyles of uremic patients. Am. J. Kidney Dis. 38:2001;296-301.
33. Markert M., Heterli C., Kewahara F., Fret J., Wauters J.P. Dialysed polymorphonuclear neutrophil oxidative metabolism during dialyses: a comparative study with 5 new and reused membranes. Clin. Nephrol. 29:1988;129-136.
34. Cristol J.P., Canaud B., Rabesandratana H., Gaillard I., Serre A., Mion C. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol. Dial. Transplant. 9:1994;389-394.
35. Ha H., Yu M.R., Choi H.N., Cha M.K., Kong H.S., Kim M.H., Lee H.B. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit. Dial. Int. 20:2000;S10-18.
36. Santos M.T., Valles J., Aznar J., Vilches J. Determination of plasma malonaldehyde-like materials and its clinical application in stroke patients. J. Clin. Pathol. 33:1980;973-976.
37. Rigatto C., Singal P.K. Oxidative stress in uremia: impact on cardiac disease in dialysis patients. Semin. Dial. 12:1999;91-96.
38. Marx J.L. Oxygen free radicals linked to many diseases. Science. 235:1987;529-531.
39. Anderson D., Yu T.-W., Wright J., Ioannides C. An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients. Mutat. Res. 398:1998;151-161.
40. Şardaş S., Yilmaz M., Öztok U., Çakir N., Karakaya A.E. Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation. Mutat. Res. 490:2001;123-129.
41. E. Nikki, in: O. Hayaishi, M. Mino (Eds.), Clinical and Nutritional Aspects of Vitamin E, Elsevier, Amsterdam, 1986, pp. 3-14.
42. Duthie S.J., Ma A., Ross M.A., Collins A.R. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 56:1996;1291-1295.
43. Mydlik M., Derzsiova K., Racz O., Sipulova A., Lovasova E., Petrovicova J. A modified dialyzer with Vitamin E and antioxidant defense parameters. Kidney Int. Suppl. 78:2001;144-147.
44. Maccarrone M., Meloni C., Manca-di-Villahermosa S., Cococcetta N., Casciani C.U., Finazzi-Agro A., Taccone-Galluci M. Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. Am. J. Kidney Dis. 37:2001;964-969.
45. Astley S., Southon S., Langrish-Smith A., Sampson M. Vitamin E supplementation and oxidative damage to DNA and plasma LDL in Type 1 diabetes. Diab. Care. 22:1999;1626-1631.
46. Chan A.C. Vitamin E and atherosclerosis. J. Nutr. 128:1998;1593-1596.